Experiment 510369

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

ANTHRALIN

Details

PropertyValue
Pharmacology
INTERLEUKIN-1 RELEASE STIMULATION
Administration routeEXTERNAL
OrganismEmpty organism
CitationYAMAMOTO,S: JIANG,H: KATO,R:. (1994). INHIBITION OF ANTHRALIN-CAUSED SKIN TUMOR PROMOTION AND INTERLEUKIN-1ALPHA PRODUCTION BY POTENT IMMUNOSUPPRESSANT FK506.. 83(1/2)
Amount utilized
Compound isolated
Dose amount10.0 MICROMOLS
Number2
Qualitative resultACTIVE
AnimalMOUSE
Per unitANIMAL
Dose expressionCONC USED
GenderFEMALE